LTS:0RDU (Spain)  
Grifols SA logo

Grifols SA

€ 13.70 (-0.87%) Aug 15
On watch
P/E:
106.00
P/B:
1.48
Market Cap:
€ 5.82B ($ 5.92B)
Enterprise V:
€ 14.81B ($ 15.06B)
Volume:
25.29K
Avg Vol (2M):
230.02K
Also Trade In:
Volume:
25.29K
Market Cap €:
5.82B
Market Cap $:
5.92B
PE Ratio:
106.00
Avg Vol (2-Month):
230.02K
Enterprise Value €:
14.81B
Enterprise Value $:
15.06B
PB Ratio:
1.48
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Grifols SA
NAICS : 325412
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Description
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 77% of sales in 2021. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 15% of revenue following the Novartis and Hologic deals.

Financials (Next Earnings Date:2022-11-15 Est.)

LTS:0RDU's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 1,542.899
EPS (TTM) (€) 0.13
Beta 0.28
Volatility % 41.04
14-Day RSI 33.26
14-Day ATR (€) 0.546236
20-Day SMA (€) 14.7195
12-1 Month Momentum % -22.48
52-Week Range (€) 13.035 - 22.54
Shares Outstanding (Mil) 678.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Grifols SA Filings

Document Form Filing Date
No Filing Data